| Product Name | MF | CAS | Details |
|---|
| ethyl (S)-4-((3,5-dichloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylate | C20H24Cl2N4O4 | 2520114-19-4 | Details |
| Valsartan Impurity 89 | C14H10ClN | 136304-93-3 | Details |
| diethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate | C45H42N6O4 | 144690-53-9 | Details |
| 5-CARBETHOXYURACIL | C7H8N2O4 | 28485-17-8 | Details |
| N1-ethyl-N2-(4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2-yl)ethane-1,2-diamine hydrochloride | C21H28FN3 | 2243798-59-4 | Details |
| (S)-4-((3,5-dichloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid | C18H20Cl2N4O4 | 1643811-26-0 | Details |
| Cycloocta[b]pyridine, 2-chloro-4-(3-fluorophenyl)-5,6,7,8,9,10-hexahydro- | C17H17ClFN | 132813-15-1 | Details |
| INDEX NAME NOT YET ASSIGNED | C28H28N6O3 | 2518152-88-8 | Details |
| 2-Pyrimidinamine, N-(2,4-dimethoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)- | C21H19N5O4 | 1942853-78-2 | Details |
| 2-Chloro-4-(4-fluorophenyl)-5，6，7，8，9，10-hexahydrocycloocta[b]pyridine | C17H17ClFN | 132813-14-0 | Details |
| Dabigatran iMpurity O | C27H28N6O4 | 948551-71-1 | Details |
| ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride | C29H33ClN6O4 | 1354727-65-3 | Details |
| Avanafil Impurity R-2 | C8H10Cl3NO | 38057-59-9 | Details |
| Blonanserin Impurity I | C7H16N2 | 49860-76-6 | Details |
| Dabigatran Impurity 38 | C30H33N7O5 | 1416446-40-6 | Details |
| β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester | C26H27N7O3 | 771459-37-1 | Details |
| N-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine | C18H28N4O3 | 652140-02-8 | Details |
| Cycloocta[b]pyridin-2-amine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- | C17H19FN2 | 2518376-10-6 | Details |
| methyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl) propanoate hydrochloride | C21H23Cl3N2O5S | 2758051-12-4 | Details |
| 2-Propenamide, N-[3-[[4-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]phenyl]- | C27H28F3N7O3 | 1888303-01-2 | Details |
| Dabigatran Impurity 18 | C21H23N3O4 | 1422435-35-5 | Details |
| DMDO | C5H6O3 | 37830-90-3 | Details |
| (R)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoic acid | C10H13NO4S | 1270132-45-0 | Details |
| Olmesartan Impurity 52 | C8H10N2O4 | 58954-23-7 | Details |
| Nintedanib-013-CO | C17H13NO4 | 2218446-42-3 | Details |
| midazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-hydroxyphenyl)-5-methyl-7-propyl- | C15H16N4O2 | 910554-78-8 | Details |
| Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-5,7-dimethyl- | C20H26N6O4S | 224785-72-2 | Details |
| 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline | C9H9Cl2N | 89315-56-0 | Details |
| (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid | C16H11NO4 | 1253768-91-0 | Details |
| 3-Amino-4-(carboxymethyl)benzoic acid | C9H9NO4 | 1373232-85-9 | Details |
| Boc-3-(Methylsulfonyl)-L-Phenylalanine | C15H21NO6S | 1289646-76-9 | Details |
| 5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole | C33H26N4 | 124750-53-4 | Details |
| Blonanserin Impurity 18 | C19H24FN3 | 1477480-40-2 | Details |
| 1-Piperazinecarboxylic acid, 4-[2-[methyl(4-nitrophenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester | C18H26N4O5 | 1277571-69-3 | Details |
| β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester | C34H41N7O5 | 1873316-88-1 | Details |
| Blonanserin Impurity 15 | C17H17ClFN | 132813-16-2 | Details |
| 2-Propenenitrile, 3-amino-3-(3-fluorophenyl)- | C9H7FN2 | 71682-85-4 | Details |
| 4-(2-Cyanophenyl)benzyl alcohol | C14H11NO | 154709-19-0 | Details |
| Blonanserin iMpurity | C23H30FN3 | 132810-83-4 | Details |
| Desfluoro Hydroxy Blonanserin | C23H31N3O | 132812-29-4 | Details |
| 1,3-Benzenediamine, 4,6-dimethoxy-N1-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- | C21H21N5O2 | 1942853-79-3 | Details |
| ifitegrast impurity C | C20H20Cl2N2O5S | 851785-70-1 | Details |
| 2'-(Triphenylmethyltetrazol-5-yl)biphenyl-4-yl]carboxaldehyde;Olmesartan Impurity 81 | C33H24N4O | 155983-56-5 | Details |
| Dabigatran Impurity 10 (DABRC-10) | C35H43N7O5 | 1304574-20-6 | Details |
| Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]- | C14H15N3O2S | 1135952-91-8 | Details |
| Cycloocta[b]pyridin-2(1H)-one, 4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydro- | C17H18FNO | 132812-74-9 | Details |
| 4-hydroxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazine-2-yl)phenylsulfonic acid | C15H16N4O5S | 910554-77-7 | Details |
| N-(4-Nitrophenyl)-2,2,2-trichloroacetamide | C8H5Cl3N2O3 | 4306-32-5 | Details |
| (4-ETHOXY-2-OXO-2,5-DIHYDRO-PYRROL-1-YL)-ACETIC ACID | C8H11NO4 | 142274-08-6 | Details |
| Lifitegrast Impurity 51 | C10H14ClNO4S | 2177264-60-5 | Details |
| Dabigatran Etexilate iMpurity C4 | C32H37N7O5 | 1416446-43-9 | Details |
| Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-ethoxyphenyl)-5,7-dimethyl- | C15H16N4O2 | 224789-20-2 | Details |
| N1-(4-NITROPHENYL)-2-CHLOROACETAMIDE | C8H7ClN2O3 | 17329-87-2 | Details |
| 2-chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine 1-oxide | C17H17ClFNO | 143213-96-1 | Details |
| 2-Propenamide, N-[2,4-dimethoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- | C24H23N5O3 | 1942853-18-0 | Details |
| 4'-(azidomethyl)-[1,1'-biphenyl]-2-carboxylic acid | C14H11N3O2 | 2758005-15-9 | Details |
| Irbesartan Impurity 24 | C14H12N4O | 2763750-28-1 | Details |
| 1H-Indole-6-carboxylic acid, 3-[[[4-[(2-chloroacetyl)methylamino]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-, methyl ester, (3Z)- | C26H22ClN3O4 | 1987887-93-3 | Details |
| ethyl 3-(2-(chloroMethyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate | C20H21ClN4O3 | 1307233-94-8 | Details |
| Dabigatran Impurity 10 | C21H24N4O3 | 1422435-37-7 | Details |
| (S)-5-((Tert-butylamino)methyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | C18H26FN3O3 | 1215006-08-8 | Details |
| Linezolid Impurity 12 | C20H28FN3O4 | 1215006-11-3 | Details |
| 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, ethyl ester | C32H35N5O4 | 2295911-98-5 | Details |
| Vardenafil Impurity | C19H24N4O5S | 2411340-43-5 | Details |
| Acetamide, N-[(3-chloro-4-methoxyphenyl)methyl]- | C10H12ClNO2 | 726205-58-9 | Details |
| Cycloocta[b]pyridine, 2-chloro-4-(4-chlorophenyl)-5,6,7,8,9,10-hexahydro- | C17H17Cl2N | 132813-22-0 | Details |
| 5-Pyrimidinecarboxamide, 4-[[(3-chlorophenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)- | C22H24ClN7O2 | 330786-28-2 | Details |
| Dabigatran Etexilate iMpurity O | C35H43N7O5 | 1349500-09-9 | Details |
| Olmesartan Medoxomil Impurity 32 | C49H46N6O6 | 1040405-56-8 | Details |
| Dabigatran iMpurity E | C20H22N4O3 | 1456889-80-7 | Details |
| Blonanserin Impurity 10 | C23H30ClN3 | 132810-87-8 | Details |
| 3-Fluorobenzoylacetonitrile | C9H6FNO | 21667-61-8 | Details |
| N-Desethyl-N-Methyl Vardenafil | C22H30N6O4S | 224785-87-9 | Details |
| N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline | C18H19FN2O3 | 1027135-00-7 | Details |
| Dabigatran Impurity 24 | C38H49N7O5 | 2243727-83-3 | Details |
| N-[1-[3-(2-Ethoxyphenyl)-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]acetamide | C15H18N4O3 | 1417529-59-9 | Details |
| 3-amino-3-(4-fluorophenyl)propanenitrile | C9H9FN2 | 1270488-91-9 | Details |
| Dabigatran Impurity | C34H41N7O5 | 2096992-14-0 | Details |
| 4-Amino-N-methylaniline | C7H10N2 | 623-09-6 | Details |
| Acetamide, 2-chloro-N-methyl-N-(2-nitrophenyl)- | C9H9ClN2O3 | 2653-15-8 | Details |
| C3-NITRO-4-METHYLAMINO-BENZOYLCHLORIDE | C8H7ClN2O3 | 82357-48-0 | Details |
| Cycloocta[b]pyridin-2(1H)-one, 5,6,7,8,9,10-hexahydro-4-phenyl- | C17H19NO | 132812-71-6 | Details |
| Acetamide, 2-hydroxy-N-methyl-N-(4-nitrophenyl)- | C9H10N2O4 | 1860012-61-8 | Details |
| 2-Propenamide, N-[3-[[2-[[2-methoxy-4-(1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]- | C25H26F3N7O2 | 2763827-03-6 | Details |
| N-ACETYLOXINDOLE 97 | C10H9NO2 | 21905-78-2 | Details |
| Dabigatran Etexilate Impurity 64 | C9H10N2O3 | 355809-32-4 | Details |
| Osimertinib Impurity I | C22H25ClN6O | 2044702-55-6 | Details |
| 2(e),4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetraazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester | C48H44N6O6 | 1203671-69-5 | Details |
| INDEX NAME NOT YET ASSIGNED | C22H26N6O6 | 2410649-54-4 | Details |
| Dabigatran Etexilate Impurity 82 | C16H18N4O3 | 1771756-20-7 | Details |
| Ethanone, 1-[4-[4-[[2-[(3-aminophenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]-3-methoxyphenyl]-1-piperazinyl]- | C24H26F3N7O2 | 2044703-15-1 | Details |
| 1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester | C18H16N4O2 | 1970195-83-5 | Details |
| Avanafil Impurity | C15H17N3O4 | 1309798-84-2 | Details |
| Avanafil Impurity 56 | C16H18ClN3O4S | 330785-82-5 | Details |
| Dabigatran Etexilate iMpurity D | C19H20N4O3 | 1422435-40-2 | Details |
| N-[3-AMino-4-(MethylaMino)benzoyl]-N-2-pyridinyl-β-alanine Methyl Ester | C17H20N4O3 | 1369510-38-2 | Details |
| Dabigatran Impurity 16 | C26H24N6O3 | 211916-39-1 | Details |
| Dabigatran Impurity 19 | C34H41N7O5 | 2225986-94-5 | Details |
| Product Total： Product Page： | ||||
| 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 | ||||